Skip to main content

Hepatocellular Adenoma

  • Chapter
Benign Tumors of the Liver

Abstract

Hepatocellular adenoma is one of the benign tumors which may occur in the liver. Solitary adenoma is more frequent in women, especially associated with the use of oral contraceptives or anabolic steroids. Glycogen storage disease and mutation of HNF1A gene are associated with an increased incidence of adenomas. It is usually asymptomatic and found incidentally. MRI is used to suspect the diagnosis which should be confirmed by liver biopsy. Recently, adenomas have been usually divided in four types with different characteristics (Bordeaux classification): adenoma with HFN1A gene mutation, adenoma with B-catenin gene mutation, adenoma without any markers, and inflammatory adenomas. It has been reported with an increasing risk of bleeding (up to 25 %) or tumor transformation (up to 9 %) based on histologic classification (B-catenin mutation) and size. Surgical resection is usually recommended in case of tumor size larger than 5 cm, B-catenin mutation, presence of symptoms, evidence of dysplasia or atypia at the biopsy, or features of malignant transformation (increase size at the follow-up). Early postoperative outcome after partial hepatectomy has been reported excellent as well as long-term results. In case of adenomatosis (more than ten adenoma), surgical resection of the greatest lesions may be recommended; however, liver transplantation may be considered in case of diffuse disease, and it has been reported as an exceptional indication in 0.09 % of all indications in the world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Flejou JF, Barge J, Menu Y et al (1985) Liver adenomatosis: an entity distinct from liver adenoma? Gastroenterology 89:1132–1138

    CAS  PubMed  Google Scholar 

  2. Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89

    Article  PubMed  Google Scholar 

  3. Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Flejou JF, Zucman-Rossi J (2006) Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol 45(6):883–886

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptives. JAMA 242(7):644–648

    Article  CAS  PubMed  Google Scholar 

  5. Lin H, Van den Esschert J, Liu C, Van Gulik T (2011) Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol 26:28–35

    Article  PubMed  Google Scholar 

  6. Lee PJ (2002) Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 161(Suppl 1):S46–S49

    Article  CAS  PubMed  Google Scholar 

  7. Steinbrecher UP, Lisbona R, Huang SN, Mishikin S (1981) Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 26(11):1045–1050

    Article  CAS  PubMed  Google Scholar 

  8. Torbeson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT (2002) Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signalling pathway. Mod Pathol 15(3):189–196

    Article  Google Scholar 

  9. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24(3):276–279

    Article  CAS  PubMed  Google Scholar 

  10. Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, Chen YT, Kishnani PS (2007) Glycogen storage disease type III-hepatocellular carcinoma a long term complication? J Hepatol 46(3):492–498

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605(2):217–245

    CAS  PubMed  Google Scholar 

  12. Pelletier L, Rebouissou S, Paris A et al (2010) Loss of HNF1αfunction in human hepatocellular adenomas leads to aberrant activation os signaling pathways involved in tumorigenesis. Hepatology 51:557–566

    Article  CAS  PubMed  Google Scholar 

  13. Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C et al (2009) Frequent inframe somatic deletion activate gp130 in inflammatory hepatocellular tumors. Nature 57:200–204

    Article  Google Scholar 

  14. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524

    Article  CAS  PubMed  Google Scholar 

  15. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748

    Article  CAS  PubMed  Google Scholar 

  16. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481–489

    Article  PubMed  Google Scholar 

  17. Cobey FC, Salem RR (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187:181–191

    Article  PubMed  Google Scholar 

  18. Edmondson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470–472

    Article  CAS  PubMed  Google Scholar 

  19. Kerlin P, Davis GL, McGill DB, Weiland LH et al (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology 84:994–1002

    CAS  PubMed  Google Scholar 

  20. Mathieu D, Bruneton JN, Drouillard J et al (1986) Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 160:53–58

    Article  CAS  PubMed  Google Scholar 

  21. Leese T, Farges O, Bismuth H (1988) Liver cell adenomas: a 12-year surgical experience from a specialist hepatobiliary unit. Ann Surg 208:558–564

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Iwatsuki S, Todo S, Starzl TE (1990) Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet 171:240–246

    PubMed Central  CAS  PubMed  Google Scholar 

  23. Arrive L, Flejou JF, Vilgrain V et al (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507–512

    Article  CAS  PubMed  Google Scholar 

  24. Pertschy J, Ruckert JC, Manger T (1994) Diagnosis and surgical therapy of benign liver tumors. Zentralbl Chir 119:495–500

    CAS  PubMed  Google Scholar 

  25. Chung J, Ferzli G, David A, Kiel T (1995) Laparoscopic resection of a large hepatic tumor. Surg Endosc 9:733–735

    Article  Google Scholar 

  26. Nagorney DM (1995) Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 19:13–18

    Article  CAS  PubMed  Google Scholar 

  27. De Carlis L, Pirotta V, Rondinara GF et al (1997) Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 3:160–165

    Article  PubMed  Google Scholar 

  28. Ott R, Hohenberger W (1998) Focal nodular hyperplasia and liver cell adenoma: operation or observation? Zentralbl Chir 123:145–153

    CAS  PubMed  Google Scholar 

  29. Closset J, Veys I, Peny MO et al (2000) Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 47:1382–1384

    CAS  PubMed  Google Scholar 

  30. Ichikawa T, Federle MP, Grazioli L et al (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214:861–868

    Article  CAS  PubMed  Google Scholar 

  31. Reddy KR, Kligerman S, Levi J et al (2001) Benign and solid tumors of the liver: relationship to sex, age, size of tumors and outcome. Am Surg 67:173–178

    CAS  PubMed  Google Scholar 

  32. Terkivatan T, de Witt JH, de Man RA et al (2001) Indications and long term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038

    Article  CAS  PubMed  Google Scholar 

  33. Descottes B, Glineur D, Lachachi F et al (2003) Laparoscopic liver resection of benign liver tumors. Surg Endosc 17:23–30

    Article  CAS  PubMed  Google Scholar 

  34. Toso C, Majno P, Andreas A et al (2005) Management of hepatocellular adenoma: solitary uncomplicated, multiple and ruptured tumors. World J Gastroenterol 11:5691–5695

    PubMed  Google Scholar 

  35. Erdogan D, Busch OR, van Delden OM et al (2006) Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 26:433–438

    Article  PubMed  Google Scholar 

  36. Van der Windt DJ, Kok NF, Hussain SM et al (2006) Case-oriented approach to the management of hepatocellular adenoma. Br J Surg 93:1495–1502

    Article  PubMed  Google Scholar 

  37. Chaib E, Gama-Rodrigues J, Ribeiro MA et al (2007) Hepatic adenoma. Timing for surgery. Hepatogastroenterology 54:1382–1387

    CAS  PubMed  Google Scholar 

  38. Koffron AJ, Auffenberg G, Kung R, Abecassis M (2007) Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 246:385–392; discussion 92–94

    Article  PubMed Central  PubMed  Google Scholar 

  39. Reddy SK, Kishnani PS, Sullivan JA et al (2007) Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47:658–663

    Article  CAS  PubMed  Google Scholar 

  40. Buell JF, Thomas MT, Rudich S et al (2008) Experience with more than 500 minimally invasive hepatic procedures. Ann Surg 248:475–486

    PubMed  Google Scholar 

  41. Cho SW, Marsh JW, Steel J et al (2008) Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 15:2795–2803

    Article  PubMed  Google Scholar 

  42. Petri A, Hohn J, Kokai EL et al (2008) Surgery of benign liver tumors: indications for treatment: twenty years’ experience. Hepatogastroenterology 55:592–595

    PubMed  Google Scholar 

  43. Deneve JL, Pawlik TM, Cunningham S et al (2009) Liver cell adenoma management: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16:640–648

    Article  PubMed  Google Scholar 

  44. Dokmak S, Paradis V, Vilgrain V et al (2009) A single center surgical experience of 22 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705

    Article  PubMed  Google Scholar 

  45. Mounajjed T, Wu TT (2011) Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection. Am J Surg Pathol 35:1356–1363

    Article  PubMed  Google Scholar 

  46. Bunchorntavakul C, Bahirwani R, Drazek D et al (2011) Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 34:664–667

    Article  CAS  PubMed  Google Scholar 

  47. De Angelis N, Memeo R, Calderaro J et al (2014) Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford) 16(9):783–788

    Article  Google Scholar 

  48. Foster JH, Berman NN (1994) The malignant transformation of liver cell adenomas. Arch Surg 129:712–717

    Article  CAS  PubMed  Google Scholar 

  49. Lepreux S, Laurent C, Blanc JF, Trillaud H, Le Bail B et al (2003) The identification of small nodules in liver adenomatosis. J Hepatol 39:77–85

    Article  PubMed  Google Scholar 

  50. Flowers BF, McBurney RP, Vera SR (1990) Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg 56:380–383

    CAS  PubMed  Google Scholar 

  51. Akovbiantz A, Ackermann D, Buhler H, Schmid M (1980) Management of liver cell adenoma and focal nodular hyperplasia. Helv Chir Acta 47(5):607–609

    CAS  PubMed  Google Scholar 

  52. Yoshidome H, McMasters KM, Edwards M (1999) Management issues regarding hepatic adenomatosis. Am Surg 65:1070–1076

    CAS  PubMed  Google Scholar 

  53. Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ (1998) Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 4:388–398

    Article  CAS  PubMed  Google Scholar 

  54. Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7:186–196

    Article  Google Scholar 

  55. Tepetes K, Selby R, Webb M, Madariaga JR, Iwatsuki S, Starzl TE (1995) Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 130:153–156

    Article  CAS  PubMed  Google Scholar 

  56. Ercolani G, Grazi GL, Pinna AD (2010) Liver transplantation for benign hepatic tumors: a systematic review. Dig Surg 27:68–75

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giorgio Ercolani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing AG Switzerland

About this chapter

Cite this chapter

Ercolani, G., Zanfi, C., Cescon, M., Pinna, A.D. (2015). Hepatocellular Adenoma. In: Aldrighetti, L., Cetta, F., Ferla, G. (eds) Benign Tumors of the Liver. Springer, Cham. https://doi.org/10.1007/978-3-319-12985-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12985-3_13

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-12984-6

  • Online ISBN: 978-3-319-12985-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics